PACB stock forecast
Our latest prediction for Pacific Biosciences of California Inc's stock price was made on the March 7, 2024 when the stock price was at 4.59$.
In the short term (2weeks), PACB's stock price should underperform the market by -2.32%. During that period the price should oscillate between -20.45% and +14.97%.
In the medium term (3months), PACB's stock price should underperform the market by -9.74%. During that period the price should oscillate between -47.55% and +41.35%.
Get email alertsCreate a solid portfolio with PACB
About Pacific Biosciences of California Inc
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
At the moment the company generates 200M USD in revenues.
On its last earning announcement, the company reported a loss of -1.21$ per share.
The book value per share is 0.65$
Three months stock forecastMarch 7, 2024
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
200M | - | -334M | - | -306M | -1.21 | - | - | 267M | 0.65 | - | - | - |